Rasha Alqadi is a Lincoln, Nebraska based female rheumatologist who is specialized in Rheumatology. Active license number of Rasha Alqadi for Rheumatology is MD60761715 in Washington. Rasha Alqadi treat joint disease similar to orthopedists but do not perform surgeries. She diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Rasha Alqadi speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
M.D.
Gender:
Female
Practice Address:
2222 S 16th St Ste 401a, Lincoln, Nebraska, 68502-3785
Phone:
402-483-8744
Fax:
401-340-1623
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1356606651
NPI Enumeration Date:
12 Jul, 2012
NPI Last Update On:
19 Aug, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Rasha Alqadi are as mentioned below.
License Number
Specialization
State
Status
MD60761715
Rheumatologist
Washington
Primary
LP02526
Internal Medicine
Rhode Island
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2222 S 16th St Ste 401a, Lincoln, Nebraska
Zip:
68502-3785
Phone Number:
402-483-8744
Fax Number:
401-340-1623
Patients can reach Rasha Alqadi at 2222 S 16th St Ste 401a, Lincoln, Nebraska or can call to book an appointment on 402-483-8744. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.